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Abstract: Historic cell culture media were designed to ensure continuous cancer cell proliferation in 10 
vitro. However, their composition does not recapitulate the tumor’s nutritional environment. Recent 11 
studies show that novel media formulations alleviate the non-physiological constraints imposed by 12 
historic media, and lead to cell culture results more relevant to tumor metabolism.  13 
 14 
A tumor is a complex, dynamic and disordered structure within an organism, composed of mixed 15 
populations of normal and cancer cells. To understand the role of the biological units of this system, 16 
researchers embraced a reductionist approach over than 60 years ago when they started to culture 17 
cells in isolation. Since then, most of the experiments in cancer research have been performed with cell 18 
lines cultured as monolayers, often referred to as in vitro. Such experiments substantially contributed 19 
to the advancement of our knowledge in cancer cell biology, and it is undeniable that culturing cancer 20 
cells is informative, and has advantages that overall exceed its obvious limitations. Tumors consist of 21 
different niches depending on vascularization, genetic clonality, and infiltration of immune and stromal 22 
cells. Since a cell culture dish overtly differs from the growth conditions of cells in tumors, researchers 23 
continuously attempted to refine culture conditions by modulating oxygen concentration, by allowing 24 
cells to form self-contained three dimensional structures, i.e. spheroids, or by supplying extracellular 25 
matrixes with different chemical-physical properties. Recently, more complex co-culture systems have 26 
also allowed to study the interaction between different cell types in vitro.  27 
However, most of the experiments currently ongoing are still performed in historic cell culture media, 28 
some of which were formulated at least half a century ago, and whose composition clearly differs from 29 
the nutritional environment that cells withstand in tumors. For example, Eagle’s Minimal Essential 30 
Medium, MEM, and its Dulbecco’s modified version, DMEM, were designed to supply cancer cells with 31 
only those nutrients essential for their continuous proliferation. These media are widely used and in 32 
2016 more than half of the published cell culture-based studies employed one or other of these media 33 
[1]. Another frequently used cell culture medium, F12, was optimized for the clonal growth of Chinese 34 
Hamster Ovary (CHO) cells under reduced serum supplementation [2]. In general, currently available 35 
commercial cell culture media were formulated to allow continuous and accelerated growth of specific 36 
cell types, and not to recapitulate the metabolic environment of the tissue of origin, or the proliferation 37 
rates of tumors [2]. As a result, media often lack metabolites normally present in human fluids, while 38 
others, such as glucose, glutamine or pyruvate, are often found at supra-physiological concentrations 39 
(Supplemental Table 1). On the contrary, compounds irrelevant for human pathophysiology, such as L-40 
alanyl-L-glutamine dipeptide (e.g. GlutaMAX), are commonly supplemented at millimolar 41 
concentrations, with uncharacterized, yet inevitable consequences on cell metabolism.  42 
Only in recent years, has it been shown that excessive concentrations of nutrients affect the metabolism 43 
of cultured cells and lead to discrepancies in metabolic phenotypes between cultured cells and tumors. 44 
For example, the proliferation of cancer cells has been shown to depend less on mitochondrial 45 
respiration when cultured with excessive concentrations of pyruvate, as indicated by their decreased 46 
sensitivity to metformin [3] (Figure 1). Additionally, high concentrations of cystine found in historic media 47 
enhance glutamine consumption and dependency by cancer cells in culture [4]. Undoubtedly, the effects 48 
of culture media with non-physiological levels of nutrients are not limited to cancer cells. BrainPhys is 49 
an example of a medium developed to recapitulate specific functional phenotypes observed in the brain. 50 
In 2015, Bardy et al. formulated BrainPhys with a reduced concentration of neuroactive ions and 51 
amino acids in comparison to DMEM/F-12 and Neurobasal media. This specialized medium enabled 52 
researchers to study the electrical activity of neurons derived either from primary tissue, or from induced 53 
pluripotent stem cells, as well as in brain explants cultured ex vivo [5]. The logic applied in the designing 54 
of BrainPhys raises questions on what is currently known about the availability of nutrients and 55 
metabolites in specialized tissues, and in the tumor microenvironment. Are cells in tumors exposed to 56 
nutrient concentrations comparable to those of plasma? Do adjacent cells exchange nutrients directly 57 
through gap junctions or microtubes [6] or via extracellular interstitial fluid? Answers to these broad 58 
questions remains largely speculative, however recent evidences suggest that in poorly vascularized 59 
pancreatic adenocarcinomas, the concentrations of specific nutrients in the interstitial fluid significantly 60 
deviates from the circulating levels [7].  61 
Under a reasonable assumption that the circulating levels of metabolites constitute a relevant source 62 
of nutrients for most normal and neoplastic tissues, researchers have cultured cancer cells in serum or 63 
lymph fluid [4], [8]. However, the availability, complexity, and undefined nature of these bio-fluids limit 64 
their applicability in cancer research. In 2015 we formulated a medium with glucose, pyruvate and amino 65 
acids concentrations similar to human blood (Serum-like Modified Eagle’s Medium, SMEM, 66 
Supplemental Table 1 [9]). SMEM has lower concentrations of the amino acids found in DMEM, it has 67 
additional proteinogenic (e.g. alanine, glutamate) and non-proteinogenic amino acids (e.g. ornithine, 68 
citrulline), but still lacks many polar metabolites normally found in human plasma. In 2017, Cantor et al. 69 
described the effects on cancer cells of a more complex medium formulation with amino acid 70 
derivatives, ketone bodies, end products of organismal catabolism (e.g. urate) and other components 71 
at concentrations found in human plasma (HPLM, Supplemental Table 1 [10]). Urate is the end product 72 
of purine catabolism, and Cantor et al. reported that it can regulate the biosynthesis of the pyrimidine 73 
nucleotides by inhibiting uracil monophosphate synthetase (Figure1). This enzyme is also responsible 74 
for the activation of the drug 5-flurouracil, therefore cancer cells cultured in HPLM have been shown to 75 
be less sensitive to this anticancer drug. These observations suggest that the formulation of the cell 76 
culture medium might have profound implications in the target identification and drug development 77 
processes, in particular when these focus on cell metabolism [11]. 78 
Plasmax is a more complex iteration of the afore mentioned SMEM and, similarly to HPLM, it aims to 79 
recapitulate more closely the nutrient composition of human plasma [12]. Plasmax formulation 80 
contains 66 organic components. Amongst these, arginine and pyruvate are ~10 fold less abundant in 81 
this medium than in historic ones, such as DMEM. In triple negative breast cancer (TNBC) cells, 82 
pyruvate stabilizes the hypoxia-inducible factor 1 (HIF1) in a dose dependent manner, and at the 83 
concentrations supplemented in historic media (0.5-1mM) it induces a pseudo-hypoxic response even 84 
under atmospheric oxygen availability. Concomitantly, in cells cultured in media such as DMEM or 85 
RPMI, the high concentrations of arginine reverse the direction of the reaction catalyzed by the urea 86 
cycle enzyme, argininosuccinate lyase. This metabolic feature was not observed in cancer cells grown 87 
in Plasmax, nor in mammary orthotopic xenografts. Furthermore, in only four days of culture in 88 
Plasmax the metabolic profile of TNBC spheroids resembled the metabolic landscape of orthotopic 89 
xenografts more closely than that obtained with historic media. This indicates that the metabolism of 90 
established cancer cell lines, isolated and cultured for many passages under the non-physiological 91 
selective pressure of historic media, can be rectified towards a more tumor-like state. In addition, these 92 
observations suggest that in vitro models could be further refined by culturing cells freshly isolated from 93 
patient-derived material directly in a more physiological medium. 94 
In commonly employed media, essential components (e.g growth factors, proteins, non-polar nutrients, 95 
and trace elements) are largely provided by the serum. Hence, their concentration varies between 96 
different batches, thereby impairing the reproducibility of results between laboratories. To achieve a 97 
chemically defined medium that allows cells to be cultured without serum supplementation, essential 98 
components must be included in the formulation. Plasmax, as well as some advanced commercial 99 
media, contain trace elements such as Fe, Se, Zn, Cu in the form of salts. Human metabolism largely 100 
depends on circulating levels of these elements bound to organic small molecules and proteins such 101 
as transferrin, selenoproteins, ceruloplasmin, and albumin. Therefore, the physiological availability of 102 
these important metabolic catalysts can be achieved by supplementing relevant concentrations of trace 103 
elements, coupled with appropriate carrier molecules. Essential components are not limited to trace 104 
elements. Vitamins, hormones, lipids, proteins, and growth factors, normally contributed by serum, 105 
should also be considered in the attempt to achieve tumor-relevant media formulations.  106 
Finally, it is common cell culture practice to incubate the cells with a fixed amount of medium for 107 
extended periods. This can lead to the exhaustion of heavily consumed nutrients (e.g. glucose) and an 108 
accumulation of metabolic products (e.g. lactate) far beyond the physiological ranges reported in 109 
humans (Supplemental Table 1). This consideration applies in particular to physiological media where 110 
the concentration of nutrients has not been artificially increased to overcome this problem. An option to 111 
prevent both nutrient exhaustion in spent medium and excessive concentrations of nutrients in fresh 112 
one, is offered by a bioreactor, called nutrostat [13], which provides a constant flow of fresh and 113 
exhausted media. While this approach is widely employed in microbiology and biotechnology, it is far 114 
less practical for multiplex experiments used in cancer research. A gross approximation of a steady 115 
state level of nutrients and metabolic end-products in the cell supernatant can be achieved by adjusting 116 
the ratio between cell number, volume of medium, and time between medium renewals. This can be 117 
applied with only minor modifications of current cell culture practice, for example by increasing the 118 
frequency of medium renewal, or by adjusting the volume of medium proportionally to the number of 119 
cells. 120 
In summary, for decades cell biologists have used media disconnected from physiology. In the last 121 
decade, the growing focus on cancer cell metabolism has contributed to the exacerbation of some of 122 
the artifacts observed by culturing cells in historic media. But cell metabolism does not exist in a vacuum 123 
and the nutrient composition of media alters the gene expression [12], [14] and the epigenome [15] 124 
thereby affecting the relevance of in vitro models to cancer biology. The implications of using 125 
nutritionally skewed media in cancer research will become more evident with the use of refined and 126 
more physiologically relevant culture media by a broader research community. In parallel, more efforts 127 
to understand the nutritional environment of specialized tissues and tumors will provide us with more 128 
defined templates for designing better cellular models of cancer. 129 
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Figure Legends 133 
Figure 1: Metabolic reactions of cancer cells cultured in historic and physiological media. Arrows 134 
and text highlighted in red indicate reactions or metabolite levels enhanced in historic media, such as 135 
DMEM. Text with dashed outline and clear filling indicates nutrients and metabolites not present in 136 
DMEM. 5-FU: 5-fluorouracil, AcCoA: acetyl-coenzyme A, ASS: argininosuccinate, ATP: adenosine 137 
triphosphate, Citn: citrulline, Fum: fumarate, FUMP: 5-fluorouracil monophosphate, HIF1: hypoxia-138 
inducible factor 1, KG: -ketoglutarate, MetF: metformin, NAD: nicotinamide adenine dinucleotide, 139 
Oaa: oxaloacetate, Orn: Ornithine, Pyr: pyruvate, UMPS: uridine monophosphate synthetase.  140 
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